Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Experimental Oncology|January 18, 2008
Clinical and histopathological features of the oral mucosa in allogeneic haematopoietic stem cell transplantation patientsF Demarosi, G Lodi, A Carrassi, et al.
Leukemia Research|March 10, 1999
Low plasma stem cell factor levels correlate with in vitro leukemic growth in myelodysplastic syndromesA Cortelezzi, C Cattaneo, S Cristiani, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?A Cortelezzi, C Cattaneo, S Cristiani, et al.
Bone Marrow Transplantation|December 26, 2001
Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphomaM Magagnoli, B Sarina, M Balzarotti, et al.
Vox Sanguinis|February 27, 2016
Bone marrow donor-related variables associated with harvest outcome in HLA-haploidentical transplantation with postinfusion cyclophosphamideA Rimondo, S Bramanti, R Crocchiolo, et al.
Leukemia|October 27, 1997
In vitro effects of IL-12 and IL-2 on NK cells, cytokine release and clonogenic activity in myelodysplastic syndromes (MDS)B Sarina, A Cortelezzi, C Cattaneo, et al.
Leukemia Research|February 2, 2000
Efficacy of N-acetylcysteine and all-trans retinoic acid in restoring in vitro effective hemopoiesis in myelodysplastic syndromesA Cortelezzi, C Cattaneo, B Sarina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2009
Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell supportL Castagna, S Bramanti, A Levis, et al.
Leukemia|July 31, 2009
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre studyA Cortelezzi, M C Pasquini, A Gardellini, et al.
Bone Marrow Transplantation|August 31, 2002
Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomasL Castagna, A Bertuzzi, A Nozza, et al.
Pageof 3